comprehensive -WSS

comprehensive

author：focus 2025-10-06 13:20:13 Page View：93547

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy
Next article： At least 13 dead in Texas as scorching temps continue

focus

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Idaho abortion case may prompt more restrictions in other states

DrewAngerer/GettyImagesTheU.S.SupremeCourt’sdecisiontoconsiderthelegalityofIdaho’sabortionlaw—andtor

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

Heart disease and mental health: A look at cardiac psychology

MargeryQuackenbush,an85-year-oldpsychoanalyst,inherUpperEastSideapartmentinNewYork.OliviaFalcignofor

comprehensive

explore

focus

Heart disease and mental health: A look at cardiac psychology